Evidence map›Paper›PMID 22484345›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2012

Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure.

Brice Arnaudis, Olivier Lairez, Roger Escamilla, Audrey Fouilloux, Pauline Fournier, Benoit Monteil, Frédéric Bouisset, Jean-François Arnal, Meyer Elbaz, Didier Carrié and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The future of chronic disease management: melting pot or mosaic?Physiotherapy Canada. Physiotherapie Canada · 2015
    Article
  11. Article
  12. Observational
  13. Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter.Clinical research in cardiology : official journal of the German Cardiac Society · 2014
    Observational
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Brice ArnaudisDepartment of Cardiology, University Hospital of Rangueil, Toulouse Cedex, France.
Olivier Lairez
Roger Escamilla
Audrey Fouilloux
Pauline Fournier
Benoit Monteil
Frédéric Bouisset
Jean-François Arnal
Meyer Elbaz
Didier Carrié
Jérôme Roncalli
Atul Pathak
Michel Galinier

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystolic heart failure (SHF) and chronic obstructive pulmonary disease (COPD) are frequently associated. The purpose of our study was to explore the impact of COPD severity on symptoms and prognosis in patients with SHF. METHODS AND

resultsChronic obstructive pulmonary disease was systematically screened by spirometry in 348 patients admitted for SHF from April 2002 to December 2006. Severity of COPD was defined according to the GOLD classification. Prevalence of COPD was 37.9 %. Patients' distribution according to GOLD stages I, II, II and IV were, respectively, 51.5, 37.9, 7.6 and 3.0 %. Severity of dyspnoea increases with GOLD stage. There was a significant correlation between NYHA stage and left ventricular ejection fraction in patients without COPD (R (2) = 0.03; P = 0.01) but not in patients with COPD. Mean follow-up was of 54.9 ± 27.4 months. Mortality was 46.6 % and was highest in the COPD group (53.8 vs. 42.3 %; P = 0.049). Kaplan-Meier survival curves showed that patients with GOLD stage I had the same prognosis than patients without COPD and mortality increased from GOLD stage II to stage IV. After multivariate analysis, GOLD stage and diuretics' dose were independently associated with mortality.

conclusionsChronic obstructive pulmonary disease is frequent in patients with SHF and increases mortality. Since dyspnoea is poorly specific of COPD in chronic heart failure patients, COPD remains underdiagnosed thus leading to inappropriate increase of diuretics' dose. COPD should be systematically screened in patients with SHF to adapt prescription of selective β1-blockers, and diuretics' dose and reduce the exposition to risk factors.

Indexed as

AdultAgedDiureticsDose-Response Relationship, DrugDyspneaFemaleFollow-Up StudiesHeart Failure, SystolicHumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisPrevalencePrognosisProspective StudiesDiuretics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.